Cube Labs SpA

Cube Labs SpA OCF Margin

The Operating Cash Flow Margin of Cube Labs SpA (CUBE.MI) as of Oct 27, 2026 is -56.35 %. In the previous year, Operating Cash Flow Margin was -94.90 % — a change of -40.62% (higher).

OCF Margin

-56.35 %

YoY

-40.62%

Last updated:

Operating Cash Flow Margin of Cube Labs SpA is 2025 -56.35 % . Operating Cash Flow Margin of Cube Labs SpA was 2024 -94.90 % . It decreases by -40.62% higher compared to the previous year.

The Cube Labs SpA OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2020
-54.30 EUR
Jan 1, 2021
-33.22 EUR
Jan 1, 2022
-112.03 EUR
Jan 1, 2023
-140.78 EUR
Jan 1, 2024
-94.90 EUR
Jan 1, 2025
-56.35 EUR
The Cube Labs SpA OCF Margin history
YEAROCF MarginYoY
-56.35 %-40.62%
-94.90 %-32.59%
-140.78 %+25.66%
-112.03 %+237.25%
-33.22 %-38.82%
-54.30 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cube Labs SpA Stock analysis

What does Cube Labs SpA do? Cube Labs SpA generates revenue through healthcare technology services, focusing on creating and supporting companies from the R&D stage. The firm provides entrepreneurial and operational support for healthcare management and technology solutions, targeting global markets. It promotes and implements scientific research results in human health, biotechnology, and nanotechnology, serving clients seeking innovative healthcare technology integration. The company operates with a lean team of two full-time employees, leveraging its expertise in translating research into practical applications. Cube Labs SpA's business model centers on bridging the gap between scientific research and market-ready healthcare technology. By offering tailored support for startups in the healthcare sector, the company helps clients navigate the complexities of R&D commercialization. Its global operations allow it to serve clients across different regions, capitalizing on the increasing demand for advanced healthcare solutions. The firm's revenue streams are derived from its specialized services in healthcare technology development and implementation. The company's primary clients are healthcare technology startups and established firms looking to integrate scientific research into their operations. Cube Labs SpA supports these clients through its expertise in biotechnology and nanotechnology applications, delivering customized solutions that address specific market needs. With a focus on operational support and entrepreneurial guidance, the firm helps clients accelerate their time-to-market for innovative healthcare products. Cube Labs SpA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cube Labs SpA stock

Operating Cash Flow Margin of Cube Labs SpA is -56.35 % in 2025.

Operating Cash Flow Margin of Cube Labs SpA changed from -94.90 % to -56.35 %, representing a -40.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Cube Labs SpA since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Cube Labs SpA with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Cube Labs SpA

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Cube Labs SpA